Unique ID issued by UMIN | UMIN000018852 |
---|---|
Receipt number | R000021806 |
Scientific Title | Efficacy and safety of Antithrombin III administration for the patients with blood coagulation disorder after hepatectomy. |
Date of disclosure of the study information | 2015/09/20 |
Last modified on | 2020/02/09 16:47:48 |
Efficacy and safety of Antithrombin III administration for the patients with blood coagulation disorder after hepatectomy.
Efficacy and safety of Antithrombin III administration for the patients with blood coagulation disorder after hepatectomy.
Efficacy and safety of Antithrombin III administration for the patients with blood coagulation disorder after hepatectomy.
Efficacy and safety of Antithrombin III administration for the patients with blood coagulation disorder after hepatectomy.
Japan |
Blood coagulation disorder after hepatectomy
Surgery in general | Hepato-biliary-pancreatic surgery |
Malignancy
NO
Compare the efficacy and safety of Antithrombin III administration for the patients with blood coagulation disorder after hepatectomy.
Safety,Efficacy
Confirmatory
Efficacy (Posthepatectomy Liver Failure)
Safety, Morbidity rate, Mortality rate, Liver function test, Blood coagulation ability
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
YES
Institution is considered as adjustment factor in dynamic allocation.
NO
Central registration
2
Treatment
Medicine |
A: Administration of gabexate mesilate 1,500mg per day for 4 days after surgery.
B: Administration of gabexate mesilate 1,500mg per day for 4 days after surgery, and of antithrombin III 1,500mg for 2 days after surgery.
20 | years-old | <= |
Not applicable |
Male and Female
1. Hepatectomy for hepatic disease
2. Japanese Association for Acute Medicine-defined DIC criteria score > 4 on the day 1st after hepatectomy
3. Written informed consent
4. > = 20 years of age
1. Clinically significant allergy
2. Clinically significant postoperative liver failure (T.Bil >=5.0mg/dL)
3. Clinically significant postoperative complication
4. Significant lack of antithrombin III (<30%)
5. Splenectomy
6. Presence of anastomosis of alimentary or biliary truct
7. Presence of biliary drainage
8. Clinically significant coagulopathy, renal disfunction or infection
9. Presence of psychological disorder
140
1st name | |
Middle name | |
Last name | Ohdan Hideki |
Hiroshima University Hospital
Gasroenterological Surgery
1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, JAPAN
082-257-5222
jimukyoku@hisco-jpn.com
1st name | |
Middle name | |
Last name | Kobayashi Tsuyoshi |
Hiroshima University Hospital
Gasroenterological Surgery
1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, JAPAN
082-257-5222
http://www.hisco-jpn.com/index.html
tsukoba@hiroshima-u.ac.jp
Gasroenterological Surgery, Hiroshima University Hospital
Hiroshima University Hospital
Self funding
Japan
NO
安佐市民病院(広島県)、尾道総合病院(広島県)、広島総合病院(広島県)、県立広島病院(広島県)、広島大学病院(広島県)、中国労災病院(広島県)、東広島医療センター(広島県)、広島鉄道病院(広島県)、呉医療センター・中国がんセンター(広島県)、吉島病院(広島県)、呉市医師会病院(広島県)
2015 | Year | 09 | Month | 20 | Day |
Published
Completed
2015 | Year | 08 | Month | 25 | Day |
2015 | Year | 08 | Month | 10 | Day |
2015 | Year | 10 | Month | 01 | Day |
2019 | Year | 03 | Month | 31 | Day |
2019 | Year | 03 | Month | 31 | Day |
2019 | Year | 03 | Month | 31 | Day |
2019 | Year | 03 | Month | 31 | Day |
2015 | Year | 08 | Month | 30 | Day |
2020 | Year | 02 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021806